Loading provider…
Loading provider…
Hematology & Oncology Physician in Van Nuys, CA
NPI: 1417132499Primary Employer
Good Samaritan Medical Pavilion
lacancernetwork.com
HQ Phone
Get M.D. Shahrooz's Phone Numberphone_androidMobile
Get M.D. Shahrooz's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardCA State Medical License
2007 - 2025
CA State Medical License

American Board of Internal Medicine
Hematology

American Board of Internal Medicine
Medical Oncology
UCLA David Geffen School of Medicine/UCLA Medical Center
Fellowship • Hematology and Medical Oncology
2009 - 2012
Cedars-Sinai Medical Center
Residency • Internal Medicine
2006 - 2009
Albert Einstein College of Medicine
einsteinmed.edu
Medical School
Until 2006
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 96127Brief emotional or behavioral assessment | 686 | 1,519 |
| 2 | 99214Established patient office or other outpatient visit, 30-39 minutes | 614 | 2,093 |
| 3 | 99223Initial hospital inpatient care, typically 70 minutes per day | 543 | 715 |
| 4 | 99232Subsequent hospital inpatient care, typically 25 minutes per day | 535 | 5,419 |
| 5 | 85025Complete blood cell count (red cells, white blood cell, platelets), automated test | 519 | 1,564 |
Authors: Robert Vescio, Robert Moss, James Berenson, Gary Schwartz
Journal: Hematol Oncol
Publication Date: 2022-08-14
Improved clinical outcomes for multiple myeloma patients treated at a single specialty clinic
Authors: Youram Nassir, Nika Harutyunyan, James Berenson, James Wang
Journal: Ann Hematol
Publication Date: 2016-12-02
Authors: Eric Vail, James Berenson, Samuel Stampfer, Aaron Feinstein
Journal: Clin Infect Pract
Publication Date: 2021-12-09
Lead Sponsor: Oncotherapeutics
Collaborators: Amgen
Intervention / Treatment: DRUG: Lenalidomide, DRUG: Dexamethasone, DRUG: Prednisone, DRUG: Pomalidomide, DRUG: Carfilzomib, DRUG: Methylprednisolone
Lead Sponsor: Oncotherapeutics
Collaborators: Incyte Corporation
Intervention / Treatment: DRUG: Lenalidomide, DRUG: Methylprednisolone, DRUG: Ruxolitinib Oral Tablet [Jakafi]
Lead Sponsor: Oncotherapeutics
Collaborators: Amgen
Intervention / Treatment: DRUG: Carfilzomib and Dexamethasone